Structure & Entities
Living Systems Intelligence | CytosAI Inc. (Delaware) acts as the primary holding company. Our operational structure is designed to isolate liability while facilitating seamless IP transfer between divisions.
Interactive Model
Tax & Jurisdiction
The company utilizes a standard transfer pricing agreement between CytosAI Labs Ltd. (IP generation) and LSI Therapeutics LLC (Commercialization), compliant with OECD guidelines and Section 482 of the IRC.
Download Tax Residency Certificate (2025) →IP Assignment
All intellectual property generated by employees is automatically assigned to CytosAI Labs Ltd. Cross-licensing agreements ensure LSI Therapeutics has exclusive commercial rights for key indication areas.